US Broker Ratings

MiMedx Group, Inc (MDXG) Investor Outlook: Potential 86% Upside Makes This Biotech Stock an Intriguing Bet

MiMedx Group, Inc (NASDAQ: MDXG) is a biotechnology company specializing in healthcare solutions, with a focus on developing placental tissue allografts for medical applications. Headquartered in Marietta, Georgia, MiMedx has..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: A 162% Potential Upside Captures Investor Attention

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a notable player in the biotechnology sector, has been capturing the attention of investors with its focus on rare disease treatments. Headquartered in Princeton, New..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 142% Potential Upside with Strong Buy Ratings

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is making waves in the biotechnology sector with its promising clinical-stage developments, particularly its flagship product candidate, lorundrostat. With a market capitalization of $1.06 billion,..

Schrodinger, Inc. (SDGR) Stock Analysis: Exploring a 24.77% Potential Upside for Investors

Schrodinger, Inc. (NASDAQ: SDGR) is capturing the attention of investors with its promising potential upside of 24.77%, as indicated by the latest analyst ratings. Operating at the intersection of healthcare..

Sotera Health Company (SHC) Stock Analysis: Unlocking a 20% Upside Potential

Sotera Health Company (NASDAQ: SHC) presents a compelling opportunity for investors seeking exposure to the healthcare sector, particularly within the diagnostics and research industry. Headquartered in Broadview Heights, Ohio, Sotera..

Galapagos NV (GLPG) Stock Analysis: Navigating Biotech’s Challenges with a 1.11% Potential Upside

Galapagos NV (NASDAQ: GLPG), a Belgium-based biotechnology firm, is making headlines with its innovative focus on oncology and immunology. With a market capitalization of $1.88 billion, the company is a..

Azenta, Inc. (AZTA) Stock Analysis: Exploring a 42% Upside Potential in the Healthcare Sector

Azenta, Inc. (NASDAQ: AZTA), a noteworthy player in the healthcare sector, specializes in providing cutting-edge biological and chemical compound sample exploration and management solutions. With a current market capitalization of..

NeoGenomics, Inc. (NEO) Investor Outlook: A 48.81% Potential Upside in the Diagnostics Sector

NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the healthcare sector, specializes in diagnostics and research with a particular focus on cancer testing. Headquartered in Fort Myers, Florida, the company..

Metsera, Inc. (MTSR) Stock Analysis: A 54.66% Upside in the Biotech Arena

Metsera, Inc. (MTSR), a burgeoning name in the biotechnology sector, is capturing the attention of investors with its ambitious focus on tackling obesity and related diseases through innovative injectable and..

Edgewise Therapeutics, Inc. (EWTX) Investor Outlook: Exploring a 155% Potential Upside in the Biotech Sector

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a trailblazer in the biotechnology sector, has been capturing the attention of investors with its focus on developing treatments for muscle disorders. With a market..

Integra LifeSciences Holdings (IART): Navigating Opportunities with a 16% Potential Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART) presents a fascinating mix of opportunities and challenges for investors in the healthcare sector. As a key player in the medical devices industry, Integra’s..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Balancing Act with a 19.59% Upside Potential

Pacira BioSciences, Inc. (NASDAQ: PCRX) presents a compelling case for investors who are attuned to the dynamics of the healthcare sector, particularly within the realm of innovative non-opioid pain management..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Exploring a 125% Potential Upside Amidst Biotech Innovations

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a clinical-stage company focused on developing novel therapeutics for rare endocrine diseases, offers a compelling investment proposition with a remarkable potential upside of 125.11%. Despite..

SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: Exploring Growth Potential with Innovative Biopharmaceuticals

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) is carving a niche in the biopharmaceutical landscape with its focus on developing and commercializing treatments for rare diseases and cancer. With a market capitalization..

MannKind Corporation (MNKD) Stock Analysis: Uncovering a 135% Potential Upside in Biotech Innovations

MannKind Corporation (NASDAQ: MNKD), a prominent player in the biotechnology sector, is catching the attention of investors with a compelling growth narrative and a significant potential upside. The company, based..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Navigating Growth in the Healthcare Sector

Healthcare Services Group, Inc. (NASDAQ: HCSG), a company with a market capitalization of $1.07 billion, occupies a significant position within the healthcare sector, specifically in the medical care facilities industry...

Select Medical Holdings Corp (SEM) Stock Analysis: A 32% Upside and Strong Buy Ratings Signal Growth Potential

Select Medical Holdings Corporation (NYSE: SEM) stands out in the healthcare sector with a promising growth trajectory that appeals to investors seeking opportunities in medical care facilities. With a market..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: 34.89% Potential Upside Captures Investor Attention

For investors eyeing opportunities in the healthcare sector, U.S. Physical Therapy, Inc. (NYSE: USPH) offers a compelling proposition. With a market capitalization of $1.19 billion, this Houston-based company stands out..

Opko Health, Inc. (OPK) Stock Analysis: A Healthcare Play with 189% Potential Upside

Opko Health, Inc. (NASDAQ: OPK) stands out in the healthcare sector with its diversified operations in diagnostics and pharmaceuticals. Despite facing challenges with revenue growth and profitability, the stock presents..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a 29.90% Potential Upside in the Dynamic Healthcare Sector

Kestra Medical Technologies, Ltd. (KMTS), a pioneering force in the healthcare industry, has been capturing the attention of investors with its innovative approach to cardiovascular care. Based in Kirkland, Washington,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds